Latest News for: h3

Edit

KBRA Assigns Preliminary Ratings to CROSS 2025-H3 Mortgage Trust

Business Wire 12 Apr 2025
NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns preliminary ratings to ten classes of ...
Edit

BriaCell's Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3

Nasdaq Globe Newswire 10 Apr 2025
(“BriaPro”), are pleased to announce that BriaPro is developing novel, high affinity antibodies to B7-H3, a key player in cancer ...
Edit

Mabwell Announces NMPA Approval to Initiate Clinical Trial of novel B7-H3-targeting ADC for Advanced Solid Tumors in Combination with PD-1 Inhibitor

PR Newswire 02 Apr 2025
SHANGHAI, April 2, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its novel B7-H3-targeting ADC (R&D code ... For more information, please visit www.mabwell.com/en ... 440k+ ... 9k+ ... .
Edit

Exhibits Submission for Asset-Backed Securities Offerings (Form ABS-EE) (Morgan Stanley Capital I Trust 2018-H3)

Public Technologies 31 Mar 2025
) UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington D.C ... Morgan Stanley Capital I Trust 2018-H3 ... Morgan Stanley Capital I Trust 2018-H3 published this content on March 31, 2025, and is solely responsible for the information contained herein.
Edit

Asset-Backed Issuer Distribution Report (Form 10-D) (Morgan Stanley Capital I Trust 2018-H3)

Public Technologies 31 Mar 2025
Morgan Stanley Capital I Trust 2018-H3 ... Series 2018-H3 ... Morgan Stanley Capital I Trust 2018-H3 published this content on March 31, 2025, and is solely responsible for the information contained herein.
  • 1
×